These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1082545

  • 1. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B, Biniaminov M, Shoham C, Rosenthal E.
    N Engl J Med; 1976 Apr 08; 294(15):809-11. PubMed ID: 1082545
    [Abstract] [Full Text] [Related]

  • 2. Levamisole in the treatment of Hodgkin's disease.
    Berényi E, Kávai M, Szabolcsi M, Szegedi G.
    Acta Med Acad Sci Hung; 1979 Apr 08; 36(2):177-85. PubMed ID: 317549
    [Abstract] [Full Text] [Related]

  • 3. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y, Rotter V, Ramot B.
    Biomedicine; 1975 Jun 30; 23(6):198-200. PubMed ID: 1082352
    [Abstract] [Full Text] [Related]

  • 4. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B, Rosenthal E, Biniaminov M, Ben-Bassat I.
    Isr J Med Sci; 1981 Apr 30; 17(4):232-5. PubMed ID: 7195385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
    Dhingra VK, Gupta RK, Sadana JR.
    Res Vet Sci; 1982 Sep 30; 33(2):142-5. PubMed ID: 6983096
    [Abstract] [Full Text] [Related]

  • 7. Management of advanced Hodgkin's disease in remission.
    Klener P, Hausner P, Donner L.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Sep 30; 109(2):213-7. PubMed ID: 6179821
    [Abstract] [Full Text] [Related]

  • 8. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
    Fuks Z, Strober S, King DP, Kaplan HS.
    J Immunol; 1976 Oct 30; 117(4):1331-5. PubMed ID: 1086325
    [Abstract] [Full Text] [Related]

  • 9. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM, Fuks Z, Kaplan HS.
    Clin Exp Immunol; 1977 Sep 30; 29(3):369-75. PubMed ID: 201408
    [Abstract] [Full Text] [Related]

  • 10. Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.
    Biniaminov M, Ramot B.
    Lancet; 1975 Feb 22; 1(7904):464. PubMed ID: 48661
    [No Abstract] [Full Text] [Related]

  • 11. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G.
    Veroff Pathol; 1975 Feb 22; (0):1-99. PubMed ID: 49138
    [Abstract] [Full Text] [Related]

  • 12. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T, Jakab L, Fehér J, Cseh K.
    Allergol Immunopathol (Madr); 1982 Feb 22; 10(6):435-9. PubMed ID: 6220589
    [Abstract] [Full Text] [Related]

  • 13. The effect of levamisole on E-rosette formation by trypsinized lymphocytes.
    Lomnitzer R, Rabson AR.
    Clin Exp Immunol; 1978 Sep 22; 33(3):499-502. PubMed ID: 310743
    [Abstract] [Full Text] [Related]

  • 14. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
    Markova TP, Danilova NV.
    Ter Arkh; 1985 Sep 22; 57(7):15-8. PubMed ID: 3876611
    [Abstract] [Full Text] [Related]

  • 15. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A, Arendt M, Gan J.
    Arch Immunol Ther Exp (Warsz); 1984 Sep 22; 32(1):51-7. PubMed ID: 6332594
    [Abstract] [Full Text] [Related]

  • 16. Effect of uremic serum on E-rosette formation of normal lymphocytes modulated by levamisole.
    Modai D, Peller S, Weissgarten J, Shaked U, Kaufman S.
    Isr J Med Sci; 1981 Dec 22; 17(12):1115-8. PubMed ID: 7327910
    [Abstract] [Full Text] [Related]

  • 17. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R, Many A, Ramot B, Trainin N.
    Clin Exp Immunol; 1978 Jan 22; 31(1):111-5. PubMed ID: 639342
    [Abstract] [Full Text] [Related]

  • 18. Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's disease.
    Verhaegen H, De Cock W, De Cree J, Verbruggen F, Verhaegen-Declercq M, Brugmans J.
    Lancet; 1975 Apr 26; 1(7913):978. PubMed ID: 48151
    [No Abstract] [Full Text] [Related]

  • 19. Interference of levamisole with inhibition of E-rosette formation by Hodgkin's disease and systemic lupus erythematosus cytotoxic sera.
    Del Giacco GS, Tognella S, Leone AL, Locci F, Cornaglia P, Sangiuolo A, Grifoni V.
    Blood; 1979 May 26; 53(5):1002-6. PubMed ID: 435634
    [Abstract] [Full Text] [Related]

  • 20. Rosette-forming lymphocytes in Hodgkin's disease.
    Cohnen G, Augener W, Brittinger G, Douglas SD.
    N Engl J Med; 1973 Oct 18; 289(16):863. PubMed ID: 4543492
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.